-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Zevra Therapeutics, Inc. quarterly/annual Cost of Revenue history and growth rate from 2021 to 2023.
- Zevra Therapeutics, Inc. Cost of Revenue for the quarter ending December 31, 2023 was $2M, a 8986% increase year-over-year.
- Zevra Therapeutics, Inc. Cost of Revenue for the twelve months ending December 31, 2023 was $2.95M, a 1227% increase year-over-year.
- Zevra Therapeutics, Inc. annual Cost of Revenue for 2023 was $2.95M, a 1227% increase from 2022.
- Zevra Therapeutics, Inc. annual Cost of Revenue for 2022 was $222K, a 89.2% decline from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)